Program overview
Context
Indication: Prostate Cancer
Mechanism: Unknown
Modality: Unknown
Sponsor: Weill Medical College of Cornell University
Fractionated dose of 225Ac-J591 is flagged as watchlist signal because public records show timeline staleness. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Indication: Prostate Cancer
Mechanism: Unknown
Modality: Unknown
Sponsor: Weill Medical College of Cornell University
Registry: 1/5
Timeline: 2/5
Recruitment burden: 0/5
Results availability: 0/5
Program risk: 2/5
https://clinicaltrials.gov/study/NCT04506567
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT04506567 | Low Signal (ACTIVE_NOT_RECRUITING) | primary_completion_date_past_signal | long_recruitment_duration_signal | Low Signal | None |